Can Flanders resist the measles outbreak? Assessing vaccination coverage in different age groups among Flemish residents
- PMID: 29716667
- PMCID: PMC9184938
- DOI: 10.1017/S0950268818000985
Can Flanders resist the measles outbreak? Assessing vaccination coverage in different age groups among Flemish residents
Abstract
The Belgian strategic plan to eliminate measles contains several vaccination strategies including routine immunisation programmes and catch-up campaigns. A new expanded programme on immunisation-based survey (2016) assessed the uptake of the recommended measles-mumps-rubella (MMR) vaccine in three different cohorts: toddlers, adolescents and parents of toddlers. A two-stage cluster sampling technique was used to select 875 toddlers (age 18-24 months) and 1250 adolescents (born in 2000) from 107 municipalities in Flanders. After consent of the parent(s), 746 (85.2%) families of toddlers and 1012 (81.0%) families of adolescents were interviewed at home. Measles vaccination coverage was high at 18-24 months (96.2%) and 81.5% were vaccinated at recommended age. Toddlers who had two siblings or a non-working mother or changed vaccinator were more at risk for not being vaccinated. Coverage of the teenager dose reached 93.5% and was lower in adolescents with educational underachievement or whose mother was part-time working or with a non-Belgian background. Only 56.0% of mothers and 48.3% of fathers remembered having received at least one measles-containing vaccine. Although measles vaccination coverage in toddlers meets the required standards for elimination, administration of the teenager dose of MMR vaccine and parent compliance to the recent measles catch-up campaign in Flanders leave room for improvement.
Keywords: MMR vaccination; vaccination (immunisation); vaccines.
Conflict of interest statement
CV acts as (principal) investigator for vaccine trials conducted on behalf of the KU Leuven, for which the University obtains research grants from vaccine manufacturers; CV receives no personal remuneration for this work. PVD and HT act as (principal) investigator for vaccine trials conducted on behalf of the University of Antwerp, for which the University obtains research grants from vaccine manufacturers and the Bill & Melinda Gates Foundation; speaker's fees for presentations on vaccines are paid directly to an educational fund held by the University of Antwerp. PVD and HT receive no personal remuneration for this work. For the remaining authors none were declared.
References
-
- WHO (1999) A Strategic Framework for the Elimination of Measles in the European Region. Copenhagen: The Expanded Programme on Immunization in the European Region of WHO Measles.
-
- WHO (2012) Global Measles and Rubella Strategic Plan: 2012–2020. Geneva: WHO Press.
-
- WHO (2017) Measles outbreaks across Europe threaten progress towards elimination (press release). Copenhagen 28 March 2017. Available at http://www.euro.who.int/en/media-centre/sections/press-releases/2017/mea...
-
- ECDC (2017) Communicable Disease Threats Report Week 13, 26 March–1 April 2017. Stockholm: ECDC. Available at https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publicat...
-
- Muscat M (2011) Who gets measles in Europe? The Journal of Infectious Diseases 204(Suppl. 1), S353–S365. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
